August 20, 2024
Lipidor announces that clinical trial material for psoriasis candidate AKP02G2 has been released according to plan
STOCKHOLM, Sweden, 20th August 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that the clinical trial material…